INOpulse

Status
Phase 3
Condition
COVID-19
Intervention Type
Inhaled Drug
Funder Type
Industry

Drug Detail    

iNO stands for Inhaled Nitric Oxide. Nitric oxide is a colorless gas that is formed by the oxidation of nitrogen.

Study Purpose

This is a pilot randomized-controlled (2:1) open label investigation of inhaled NO to prevent progression to more advanced disease in 42 hospitalized patients with COVID-19, at risk for worsening, based on baseline systemic oxygenation and 2 or more of the major risk factors of age > 60 years, type II DM, hypertension, and obesity.

Find a Clinical Trial

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >